11hon MSN
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and ...
The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...
India, with over 101 million diabetes patients and rising obesity rates, faces a critical need for effective treatment ...
11hon MSN
With the growing demand for weight-loss solutions, many individuals in India have resorted to purchasing obesity drugs from ...
The drug has seen strong demand in the US and Europe, and its India launch is part of Lilly’s broader strategy to expand ...
Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...
The single-dose vial presentation has marketing authorization from the national drugs regulator—Central Drugs Standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback